Healthcare Facilities company Aster DM Healthcare announced Q2FY26 results Revenue for Q2FY26 grew 10% YoY and 11% QoQ to Rs 1,197 crore. Operating EBITDA grew 13% YoY and 22% QoQ to Rs 263 crore. in Q2FY26. Operating EBITDA Margins stood at 22.0% in Q2FY26 vs 21.4% in Q2FY25 and 20.0% in Q1FY26. Normalised PAT (Post NCI) grew 14% YoY and 23% QoQ to Rs 110 crore. In Q2FY26. Azad Moopen, Founder & Chairman, Aster DM Healthcare, said: “Aster DM Healthcare delivered a steady performance in Q2FY26, with revenue increasing 10% yearon-year to Rs 1,197 crore despite lower incidence of seasonal illness. Adjusting for thistemporary seasonal effect, the company’s underlying revenue growth stood at 13%, demonstrating the strength of its core business operations. Operating EBITDA grew by 13% YoY and 22% QoQ during the quarter, reflecting stronger cost efficiency and operating leverage across the network. The Kerala cluster demonstrated a strong turnaround in FY26, emerging from last year’s softness with renewed momentum and discipline. Following decisive leadership strengthening, operational tightening, and the revival of MVT partnerships, performance rebounded sharply. In Q2FY26, Kerala delivered its highest-ever quarterly revenue of Rs 620 crore with QoQ growth of 12%, driven by inpatient volumes growing by 13% QoQ and MVT revenue surging 67% QoQ. This momentum will further be supported with the recently operationalized 264-bedded Aster Kasaragod, strengthening our presence in northern Kerala. We have made progress on the merger with Quality Care India Ltd. with stock exchange no-objection letters now received. The combined platform will create one of India’s most integrated and scalable healthcare networks, with complementary cluster strengths and enhanced clinical depth. Together with ongoing investments in digital health and efficiency-focused operating improvements, Aster remains well-positioned to deliver sustainable, long-term growth across its key markets.” Result PDF
Healthcare Facilities company Aster DM Healthcare announced Q1FY26 results Revenue for Q1FY26 grew 8% YoY to Rs 1,078 crore vs Rs 1,002 crore in Q1FY25. Operating EBITDA grew 21% YoY to Rs 215 crore in Q1FY26 vs Rs 177 crore in Q1FY25. Operating EBITDA Margins stood at 20.0% in Q1FY26 vs 17.7% in Q1FY25. Normalised PAT (Post NCI) grew 22% YoY to Rs 90 crore vs Rs 74 crore in Q1FY25. Azad Moopen, Founder and Chairman, Aster DM Healthcare, said: “Aster DM Healthcare has delivered a strong start to FY26, recording an 8% YoY growth in revenue, reaching Rs 1,078 crore. Operating EBITDA expanded by 21%, while Profit After Tax (PAT) grew by 22%, reflecting a positive trajectory in performance. Operational metrics also demonstrated positive movement by 4% year-on-year reduction in Average Length of Stay (ALOS) to 3.1 days in Q1FY26. Additionally, Average Revenue Per Occupied Bed (ARPOB) rose 14% year-on-year to Rs 50,200 in Q1FY26 underscoring enhanced efficiency and case mix improvements. The announcement of the new hospital in Bengaluru and the additional stake hike in Aster Ramesh Hospitals marks a significant milestone in Aster’s India growth journey. In line with our long-term strategy, we are making steady progress on the proposed merger with Quality Care India Ltd. (QCIL), a move that will establish the combined entity as one of the most comprehensive and integrated healthcare networks in the country. Both Aster and QCIL have delivered strong financial performance this quarter, with their respective performances complementing each other and reinforcing the significant potential for seamless integration. With these initiatives, we remain well-positioned for sustained growth and are confident that our commitment to operational excellence, clinical innovation, and strategic expansions will allow us to redefine healthcare delivery in India”. Result PDF